XML 40 R41.htm IDEA: XBRL DOCUMENT v3.19.3
INVESTMENTS (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Jun. 30, 2019
Jul. 16, 2018
Sep. 30, 2019
Dec. 31, 2018
May 17, 2018
Equity interest acquired, percentage     100.00%    
Cash received with accounting associated     $ 2,000,000    
Diversa S.A. [Member]          
Equity method investment shares acquired, shares     40,000    
Equity method investment shares acquired, value     $ 195,418    
Closing price per share     $ 4.86    
Closing price     $ 4.89    
National Bank of Greece [Member]          
Equity method investment shares acquired, shares     16,666    
Equity method investment shares acquired, value     $ 5,076    
Net unrealized loss     $ 2,234    
Closing price     $ 0.30    
Marathon Global Inc [Member]          
Gain on exchange of investment     $ 1,953,000    
Kaneh Bosm Biotechnology Inc [Member] | Share Exchange Agreement [Member]          
Transfer of shares         2,500,000
Kaneh Bosm Biotechnology Inc [Member] | Share Exchange Agreement [Member] | Canadian Securities Exchange [Member]          
Exchange of shares         5,000,000
Consmofarm [Member]          
Cash     $ 221,457    
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member]          
Equity interest acquired, percentage     33.33%    
Cash received upon repayment for purchase common stock     $ 2,000,000    
Sale of stock, number of shares issued for distribution services     5,000,000    
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member] | Gross Sales One [Member]          
Cash received upon gross sales     $ 2,750,000    
Gross sales     13,000,000    
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member] | Gross Sales [Member]          
Cash received upon gross sales     2,750,000    
Gross sales     6,500,000    
Share exchange agreement [Member] | Unaffiliated Third Party [Member]          
Fair value of investment     163,575    
Retail trade of pharmaceutical products description The initial share capital was set to EUR 150,000 which was later increased to EUR 500,000. The GP contributed the pharmacy license (the “License”) valued at EUR 350,000 (30-year term) to operate the business of CosmoFarmacy in exchange for a 70% equity ownership. The Company is a limited partner and contributed cash of EUR 150,000 for the remaining 30% equity ownership.        
Share exchange agreement [Member] | Marathon Global Inc [Member]          
Shares of Marathon transferred by company to KBB   2,500,000      
Gain on exchange of investment   $ 2,092,200      
Share exchange agreement [Member] | ICC [Member]          
Equity method investment shares acquired   5,000,000      
Description for ownership percentage   The ten million shares of ICC owned by the Company constitute approximately 7% of the 141,219,108 shares of capital stock of KBB then issued and outstanding      
Loss on sale of equity investments     741,652    
Equity investment     $ 200,000 $ 2,500,000  
Common stock shares sold during the period     5,000,000    
Proceeds from sold of common shares     $ 1,211,348    
Fair value of investment     $ 347,000